From the Co-Chairs

August 16, 2022

From the Co-Chairs, August 2022

President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
June 21, 2022

From the Co-Chairs, June 2022

Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting
April 15, 2022

From the Co-Chairs, April 2022

Congress creates a new health care research agency; NCI-MATCH continues to offer treatment options; ECOG-ACRIN plans for first in-person Group Meeting since 2019
February 24, 2022

From the Co-Chairs, February 2022

Reflections on the 50th Anniversary of the National Cancer Act of 1971
January 26, 2022

From the Co-Chairs, January 2022

Hopes for a return to normalcy in 2022—plus, recent qualitative research identifies surprising barriers to the long-term control of breast cancer
December 22, 2021

From the Co-Chairs, December 2021

The co-chairs reflect on key 2021 accomplishments, and share their thanks and best wishes for a happy New Year
November 16, 2021

From the Co-Chairs, November 2021

Practice-changing trial results in melanoma; Group and committee leadership updates; remembering a dear colleague and friend
October 19, 2021

From the Co-Chairs, October 2021

A focus on the Fall 2021 ECOG-ACRIN Group Meeting; remembering two major leaders in oncology; studying smoking cessation in patients with cancer
September 30, 2021

From the Co-Chairs, September 2021

A focus on leukemia trials; an update regarding advanced practice providers; two important topics related to patient communication
August 23, 2021

From the Co-Chairs, August 2021

Fall 2021 Group Meeting to be virtual; a new prevention trial; the case for COVID-19 vaccination
July 7, 2021

From the Co-Chairs, June/July 2021

ECOG-ACRIN will hold its Fall 2021 Group Meeting as a face-to-face meeting for the first time in two years
May 28, 2021

From the Co-Chairs, May 2021

Virtual Spring 2021 Group Meeting generates record attendance; screening and genomic trials return to full activity